 Source: Shutterstock ChemoCentryx NASDAQ: CCXI stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen NASDAQ: AMGN . This deal has Amgen agreeing to acquire ChemoCentryx for 3.7 billion in cash. 